Zydus Cadila announced the Day 1 launch of Ramelteon Tablets (US RLD Rozerem
Tablets), 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative,
also called a hypnotic. It works by affecting certain substances in the body that help regulate
the "sleep-wake cycle." Ramelteon is used to treat insomnia that is associated with having
trouble falling asleep. The drug will be manufactured at the group's formulations
manufacturing facility at SEZ, Ahmedabad.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
